|
Name |
2-[2-(2-Hydroxyphenyl)-4,5-dihydro-1,3-thiazol-4-yl]-3-methyl-1,3-thiazolidine-4-carboxylic acid
|
| Molecular Formula | C14H16N2O3S2 | |
| IUPAC Name* |
2-[2-(2-hydroxyphenyl)-4,5-dihydro-1,3-thiazol-4-yl]-3-methyl-1,3-thiazolidine-4-carboxylic acid
|
|
| SMILES |
CN1C(CSC1C2CSC(=N2)C3=CC=CC=C3O)C(=O)O
|
|
| InChI |
InChI=1S/C14H16N2O3S2/c1-16-10(14(18)19)7-21-13(16)9-6-20-12(15-9)8-4-2-3-5-11(8)17/h2-5,9-10,13,17H,6-7H2,1H3,(H,18,19)
|
|
| InChIKey |
NYBZAGXTZXPYND-UHFFFAOYSA-N
|
|
| Synonyms |
Pyochelin; 2-(2-o-hydroxyphenyl-2-thiazolin-4-yl)-3-methylthiazolidine-4-carboxylic acid
|
|
| CAS | NA | |
| PubChem CID | 135583337 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 324.4 | ALogp: | -0.3 |
| HBD: | 2 | HBA: | 7 |
| Rotatable Bonds: | 3 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 124.0 | Aromatic Rings: | 3 |
| Heavy Atoms: | 21 | QED Weighted: | 0.889 |
| Caco-2 Permeability: | -6.152 | MDCK Permeability: | 0.00000391 |
| Pgp-inhibitor: | 0 | Pgp-substrate: | 0.003 |
| Human Intestinal Absorption (HIA): | 0.013 | 20% Bioavailability (F20%): | 0.004 |
| 30% Bioavailability (F30%): | 0.004 |
| Blood-Brain-Barrier Penetration (BBB): | 0.405 | Plasma Protein Binding (PPB): | 51.42% |
| Volume Distribution (VD): | 1.413 | Fu: | 55.16% |
| CYP1A2-inhibitor: | 0.223 | CYP1A2-substrate: | 0.173 |
| CYP2C19-inhibitor: | 0.038 | CYP2C19-substrate: | 0.306 |
| CYP2C9-inhibitor: | 0.045 | CYP2C9-substrate: | 0.609 |
| CYP2D6-inhibitor: | 0.059 | CYP2D6-substrate: | 0.27 |
| CYP3A4-inhibitor: | 0.009 | CYP3A4-substrate: | 0.097 |
| Clearance (CL): | 7.588 | Half-life (T1/2): | 0.791 |
| hERG Blockers: | 0.021 | Human Hepatotoxicity (H-HT): | 0.228 |
| Drug-inuced Liver Injury (DILI): | 0.971 | AMES Toxicity: | 0.006 |
| Rat Oral Acute Toxicity: | 0.033 | Maximum Recommended Daily Dose: | 0.837 |
| Skin Sensitization: | 0.117 | Carcinogencity: | 0.346 |
| Eye Corrosion: | 0.003 | Eye Irritation: | 0.014 |
| Respiratory Toxicity: | 0.344 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC003518 | ![]() |
0.494 | D07HBX | ![]() |
0.323 | ||
| ENC003600 | ![]() |
0.494 | D0F5ZM | ![]() |
0.278 | ||
| ENC003520 | ![]() |
0.365 | D04KTZ | ![]() |
0.266 | ||
| ENC003519 | ![]() |
0.338 | D0K0KH | ![]() |
0.263 | ||
| ENC001378 | ![]() |
0.338 | D0J5KF | ![]() |
0.263 | ||
| ENC000409 | ![]() |
0.309 | D0Z5EM | ![]() |
0.263 | ||
| ENC001547 | ![]() |
0.296 | D06VFO | ![]() |
0.260 | ||
| ENC000104 | ![]() |
0.290 | D0G7FJ | ![]() |
0.258 | ||
| ENC004704 | ![]() |
0.288 | D0R1BD | ![]() |
0.258 | ||
| ENC000108 | ![]() |
0.284 | D0D9JW | ![]() |
0.256 | ||